11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:40 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
9:26 AM | Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/05/2024
3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:00 PM | Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
10/02/2024
4:27 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:52 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:34 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:21 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:22 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:23 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:24 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:25 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:26 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:26 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:44 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:45 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:33 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:38 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:40 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:28 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:30 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
3:12 PM | Tarsus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:24 PM | Tarsus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2024
3:25 PM | Tarsus Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
7:34 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
1:56 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
1:06 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:03 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:04 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:08 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:44 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:44 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:47 PM | Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:57 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:45 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
03/11/2024
4:10 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:11 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:17 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Tarsus Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:22 PM | Tarsus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
8:18 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:28 AM | RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:06 AM | MORGAN STANLEY (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
02/02/2024
11:40 AM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
5:05 AM | Tarsus Pharmaceuticals (Subject)
TimesSquare Capital Management, LLC (Filed by)
| Form SC 13G/A | |
01/22/2024
4:05 PM | Paradigm Biocapital Advisors LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
01/18/2024
3:30 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:00 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:08 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:23 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:32 PM | Tarsus Pharmaceuticals (Issuer)
Trevejo Jose M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:49 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
2:17 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
5:30 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
